摘要
目的 :及早有效地纠正新生儿高胆红素血症 ,以预防胆红素脑损伤。方法 :对照组常规治疗 ;观察组在常规治疗的同时 ,加用必奇、聚克口服。结果 :治疗组胆红素日均下降值为 (5 0 .2 3± 2 3.35 )umol/L ,明显高于对照组 (37.98± 2 2 .13)umol/L(P <0 .0 1)。结论 :必奇、聚克用于辅助治疗新生儿高胆红素血症可迅速降低胆红素水平 ,明显缩短治疗时间。
Objective:Correct early and effectively hyperbilirubinemia of newborns and prevent cerebral damage of hyperbicirubinemia. Method: Control group was used the method of routine treatment, observational group was used the method of routine treatment and increased simultaneously oral smectite powder and lactobacillus complex capsules. Result: In observational group the value that bilirubinemia decreased daily was 50.23±23.35umol/L, and was higher than that of control group 37.98±22.13umol/L (P<0.01). Conclusion: Smectite powder and lactobacillus complex capsules can rapidly decrease the level of bilirubinemia and shorten markedly treating time in treating subserviently hyperbilirubinemia of newborns with smectite powder and lactobacillus complex capsules.
出处
《河北医学》
CAS
2004年第10期918-920,共3页
Hebei Medicine
关键词
婴儿
新生
高胆红素血症
必奇
聚克
Infant
Newborn
Hyperbicirubinemia
Smectite powder
Lactobacillus complex capsules
